Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk
- 30 November 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 103 (2) , 535-540
- https://doi.org/10.1016/j.ygyno.2006.03.046
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phytoestrogen Intake and Endometrial Cancer RiskJNCI Journal of the National Cancer Institute, 2003
- Impact of Progestin and Estrogen Potency in Oral Contraceptives on Ovarian Cancer RiskJNCI Journal of the National Cancer Institute, 2002
- Regulation of Invasion of Epithelial Ovarian Cancer by Transforming Growth Factor-βGynecologic Oncology, 2001
- Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? 1☆Journal of the Society for Gynecologic Investigation, 1998
- Progestin Treatment of Atypical Hyperplasia and Well-Differentiated Carcinoma of the Endometrium in Women Under Age 40Published by Wolters Kluwer Health ,1998
- Reproductive Factors and Risk of Endometrial Cancer The Iowa Women's Health StudyAmerican Journal of Epidemiology, 1996
- Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialJAMA, 1996
- Oral contraceptives and endometrial cancer: Do other risk factors modify the association?International Journal of Cancer, 1993
- Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinomaInternational Journal of Cancer, 1991
- The epidemiology of endometrial cancerGynecologic Oncology, 1991